您的位置: 首页 > 农业专利 > 详情页

METHOD OF TREATMENT OF MULTIPLE ORGAN FAILURE SYNDROME
专利权人:
Federalnoe gosudarstvennoe byudzhetnoe obrazovatelnoe uchrezhdenie vysshego obrazovaniya "Rostovskij Gosudarstvennyj meditsinskij universitet" Ministerstva zdravookhraneniya Rossijskoj Federatsii (FGB
发明人:
Zhenilo Vladimir Mikhajlovich (RU),Женило Владимир Михайлович (RU),Astakhov Roman Evgenevich (RU),Астахов Роман Евгеньевич (RU),Lebedeva Elena Aleksandrovna (RU),Лебедева Елена Александровна (RU),Rozi
申请号:
RU2019111262
公开号:
RU0002717070C1
申请日:
2019.04.15
申请国别(地区):
RU
年份:
2020
代理人:
摘要:
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to anaesthesiology and resuscitation, and can be used for treating multiple organ failure syndrome in newborns. That is ensured by conventional therapy. Additionally, haemofiltration is performed in a continuous extracorporeal circuit on a multiFiltrate apparatus of Fresenius company, Germany, in a continuous vein-venous haemofiltration CVVH. Program Extended daily dialysis CVVH kit, multiFiltrate-Kit paed CRRT/SCUF extracorporeal blood purification kit and UltrafluxAVpaed hemofilter. Substitute is represented by MultiBik solution of Fresenius company, Germany. Immediately before the haemofiltration procedure, the newborn's body weight (m), kg accurate to 0.001 kg, is determined. Parameters of the procedure are calculated by formulas: rate of extracorporeal blood flow (V1), ml/min, V1 = 18.0xm and rate of substitution: ml/h, respectively, in the first (V2), in the second (V3), third and subsequent hours of the procedure (V4) V2 = 80.0xm, V3 = 120.0xm and V4 = 160.0xm. Calculated value of the extracorporeal blood flow velocity V1 is rounded off to an integer multiple of 2.0 ml/min. Each calculated value of the rate of substitute V2, V3 and V4 is rounded to an integer multiple of 10.0 ml/h. Obtained values of procedure parameters are introduced into program of apparatus multiFiltrate. That is followed by one haemofiltration session lasting 10–12 hours.EFFECT: method provides effective treatment with reducing the level of lethal outcomes.1 cl, 3 exИзобретение относится к медицине, а именно к анестезиологии и реаниматологии, и может быть использовано для лечения синдрома полиорганной недостаточности у новорожденных. Для этого проводят общепринятую терапию. Дополнительно выполняют гемофильтрацию в непрерывном экстракорпоральном контуре на аппарате «multiFiltrate» фирмы «Fresenius», Германия в режиме непрерывной вено-венозной гемофильтрации CVVH. При этом используют программу «пед. CVVH», набор для экстракор
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充